The Rajasthan Drug Control Department has taken swift precautionary action by suspending the sale and use of a specific batch of Bupivacaine Hydrochloride in Dextrose injection, a widely utilized long-acting local anaesthetic. The decision follows reports from Hyderabad where 16 patients experienced severe adverse reactions—including nausea, vomiting, intense headaches, seizures, and in critical cases, required ICU admission and ventilator support—after receiving injections from the same batch.
The nationwide advisory and state-level suspension target one specific batch (Batch No. BKP02601) manufactured by Themis Medicare Limited, rather than a blanket ban on the drug itself.
What is Bupivacaine and Its Medical Use?
Bupivacaine is a critical, long-acting local anaesthetic designed to numb specific regions of the body by temporarily blocking nerve signals. Because it provides targeted pain relief without causing a patient to lose consciousness, it is a standard choice for:
- Cesarean sections (C-sections) and labor pain relief.
- Orthopedic procedures and spinal/epidural anesthesia.
- Dental surgeries and post-operative pain management.
Impact on Scheduled Surgeries and Patient Guidance
While the suspension has naturally sparked concern among patients slated for upcoming surgeries, medical experts urge the public to remain calm and avoid panic.
- Do Not Delay Essential Care: Patients are strongly advised against postponing or canceling scheduled surgeries without consulting their healthcare providers, as delaying necessary operations can pose greater health risks.
- Availability of Safe Alternatives: Hospitals across Rajasthan have already initiated recalls of the compromised batch. Healthcare facilities remain fully equipped with alternative, unaffected batches or substitute local anaesthetics like lidocaine or ropivacaine to ensure surgeries proceed safely.
- Proactive Communication: Patients should openly discuss any anxieties with their anesthesiologist prior to a procedure and disclose any history of drug allergies.
Authorities have collected thousands of injections from the affected batch across multiple districts for rigorous laboratory testing to determine the root cause of the contamination or defect. Individuals who have recently undergone surgery and experience persistent headaches, confusion, vomiting, or breathing difficulties should seek immediate medical attention.